OPE® (IPL) is a polychromatic light that thanks to thermal pulses stimulates the Meibomian glands to resume normal activities. Applied to the periorbital areas and cheekbone, it stimulates contraction of the glands, increasing the lipid stream and reducing the evaporation of tears.
LIGHT MODULATION® (LLLT) is a unique technology of photobiomodulation used for many years in various fields of medicine (dermatology, dentistry, etc.).
The emission of a particular light – to a certain wavelength – triggers an endogenous heating of the eyelids.
This treatment eases the spill – from the Meibomian glands – of the tear film’s oily component, stabilizing the lipid layer of the tear.
The treatment improves symptoms of the disease after a few hours. Thanks to the synergy of the two technologies, the Meibomian glands resume the production of lipids necessary to the eye’s functionality. It is not painful, it lasts a few minutes and allows an immediate return to normal activities. A few hours after the treatment you can appreciate an improvement of the Meibomian gland functionality.
Three sessions at different intervals (15/20 days) are necessary to achieve an optimal result.
The Dry Eye Syndrome
- Over 300 million people worldwide suffer for the Dry Eye Syndrome
- In America it involves 26% of adult population, but this syndrome mainly affects women over 40 years old (50%) and those in menopause (90%)
The tear film
The tear film, necessary to the functioning of the eye, is formed by three layers:
- A mucous layer in contact with the eye globe, secreted by the conjunctival mucus cells
- An aqueous layer secreted by the lacrimal glands
- A lipid layer secreted by the Meibomian glands
What is the dry eye
The Dry Eye is a disorder of the tear film due to a reduced production or excessive evaporation of tears, which causes damage to the exposed ocular surface, and is associated with a feeling of eye discomfort.
Excessive evaporation of tears (cause of 86% of dry eyes cases) is caused by the obstruction or malfunction of the Meibomian glands that are located in the eyelids, and are responsible for producing the lipid layer of the tears.
When not working properly, they do not produce enough oil component in the tear film, so tears evaporate more rapidly. Insufficient or absent lipid layer can cause evaporation of the tear up to 16 times faster.
- Allergic conjunctivitis
- Hormonal imbalances – Menopause
- Use and abuse of eye cosmetics
- Use of contact lenses
- Chronic blepharitis
- Age (especially after age 50)
- Computer use
- Prolonged use of systemic drugs (i.e: antihistamines, etc.)
- Air pollution
Dry eye diagnosis should always be made by the optometrist with reliable tests, thus avoiding self diagnosis and treatment “over the counter”.
The optometrist will consider a number of parameters and the correct therapy for each specific case.
There are several solutions for the dry eye problem, going from artificial tears (eyedrops) to a new generation of therapeutic treatments.
Dry eye is a multifactorial eye condition caused by either a low amount, or a low quality of tears being produced, which results in eye irritation, discomfort, and pain. One of the most common types of dry eye is Meibomian gland dysfunction, commonly known as MGD. The meibomian glands are located on the inside of the upper and lower eyelids and produce an oily component in the tear film. When this oily component is not produced due to a blockage, tears in our eyes start to evaporate faster, leading to dry eyes.
LipiFlow® was designed to clear up this blockage with a 12 minute in-office treatment that most patients describe as a gentle massaging of the eyelids.